TRX-518

N/A

Report date: 2023/09/01 20:00:50

Base Information

Drug NameTRX-518
Drug Alias NameAnti-GITR monoclonal antibody（Leap Therapeutics）Anti-TNFRSF18 monoclonal antibodyAnti-human-GITR-monoclonal-antibodyTRX-518
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti Glucocorticoid-induced tumor necrosis factor receptor-related protein
TargetsGlucocorticoid-induced tumor necrosis factor receptor-related protein
Therapy Area/IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantOvarian Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTolerx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeap Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantOvarian Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A